Questioning the photophysical model for the indolechromophore in the light of evidence obtained by controlling the non-specific effect of the medium with 1-chlorobutane as solvent

Literature Information

Publication Date 2011-07-14
DOI 10.1039/C1CP21380F
Impact Factor 3.676
Authors

Juan Pablo Catalán


View Original

Abstract

In this work, we substantiate the change in the emitting state of indole caused by the dipolarity increase in the solvent 1-chlorobutane, observed on lowering the temperature from 293 to 133 K, accompanied by no significant changes in the corresponding excitation and absorption spectra. No similar changes in indole emission were observed over the temperature range 293–133 K for solutions of indole in 2-methylbutane in the presence and absence of 0.5 M 1-chlorobutane. The solvatochromism of indole in 1-chlorobutane at temperatures from 293 to 133 K allowed us to estimate the dipole moment and polarizability of the emission state of the chromophore and to detect two states (S1 and ): one, the S1, involving no significant change and the other, the , exhibiting a substantial change in the dipole moment of the chromophore upon electronic excitation (viz. μS1 = 2.5 and vs. μS0 = 2.13 D). The former state, S1, is the major contributor to the structured emission of indole at temperatures from 293 to 193 K, as is the latter, , to its structureless, red-shifted emission over the range 193–133 K. Although the emission changes of indole, dissolved in 1-chlorobutane at temperatures from 293 to 133 K, are seemingly consistent with the widely accepted photophysical model for inversion of its 1Lb and 1La states as the polarity of the medium is increased, below 133 K the emission becomes structured and blue-shifted, two typical features of indole above 193 K. Also, below 123 K is not feasible to photo-select the 1La state in spite of this state being the first excited electronic state of indole under large dipolarity conditions. Therefore, the established photophysical model cannot hold under these conditions and a new one accounting for these experimental facts is proposed instead.

Related Literature

Contents list

2021-02-04 Front/Back Matter

DOI: 10.1039/D1MD90004H

Correction: Truncated S-MGBs: towards a parasite-specific and low aggregation chemotype

Daniel P. Brooke, Leah M. C. McGee, Federica Giordani, Jasmine M. Cross, Abedawn I. Khalaf, Craig Irving, Craig D. Shaw, Katharine C. Carter, Michael P. Barrett, Colin J. Suckling, Fraser J. Scott

2021-11-26 Correction

DOI: 10.1039/D1MD90044G

Synthesis and biological screening of a library of macamides as TNF-α inhibitors

Víctor Tena Pérez, Andreea Madalina Serban, Javier Acero Gómez, Ángel Rumbero Sánchez

2020-08-06 Research Article

DOI: 10.1039/D0MD00208A

Insights into the modular design of kinase inhibitors and application to Abl and Axl

Sameer Phadke, Lluis Lopez-Barcons, Nathalie Vandecan, Zhifen Wu, Taylor K. Johnson, Eric J. Lachacz, Sofia D. Merajver, Matthew B. Soellner

2021-11-05 Research Article

DOI: 10.1039/D1MD00296A

Small molecule-mediated induction of endoplasmic reticulum stress in cancer cells

Virender Kumar Sharma, Ankur Biswas, Mayurika Lahiri, Sudipta Basu

2021-07-15 Research Article

DOI: 10.1039/D1MD00095K

Functionalized gold nanoparticles: promising and efficient diagnostic and therapeutic tools for HIV/AIDS

Shikha Gulati, Parinita Singh, Anchita Diwan, Ayush Mongia, Sanjay Kumar

2020-10-01 Review Article

DOI: 10.1039/D0MD00298D

Back cover

Cover

DOI: 10.1039/D0MD90038A

4-Nitrophenyl activated esters are superior synthons for indirect radiofluorination of biomolecules

Peter D. Roselt

2020-07-07 Research Article

DOI: 10.1039/D0MD00140F

Discovery of isoxazolyl-based inhibitors of Plasmodium falciparum cGMP-dependent protein kinase

Shams Ul Mahmood, Huimin Cheng, Sreedhar R. Tummalapalli, Ramappa Chakrasali, Rammohan R. Yadav Bheemanaboina, Tamara Kreiss, Agnieska Chojnowski, Tyler Eck, John J. Siekierka, David P. Rotella

2019-12-16 Research Article

DOI: 10.1039/C9MD00511K

Functionalized resorcinarenes effectively disrupt the aggregation of αA66-80 crystallin peptide related to cataracts

Kwaku Twum, Avik Bhattacharjee, Erving T. Laryea, Josephine Esposto, George Omolloh, Shaelyn Mortensen, Maya Jaradi, Naomi L. Stock, Bianca Elias, Elan Pszenica, Theresa M. McCormick, Ngong Kodiah Beyeh

2021-11-01 Research Article

DOI: 10.1039/D1MD00294E

You might also like

155412-88-71-(3-Aminophenyl)-3-...
Compound Q&A

How should waste containing 1-(D-Ribofuranosyl)-1,4-dihydro-3-pyridinecarboxamide (CAS: 19132-12-8) be handled?

Waste containing 1-(D-Ribofuranosyl)-1,4-dihydro-3-pyridinecarboxamide (CAS: 191...

19132-12-81-(D-Ribofuranosyl)-...
Compound Q&A

What regulatory guidelines apply to 2-Methyl-2-propanyl 3-bromo-3-(hydroxymethyl)-1-azetidinecarboxylate (CAS: 2007919-81-3)?

2-Methyl-2-propanyl 3-bromo-3-(hydroxymethyl)-1-azetidinecarboxylate (CAS: 20079...

2007919-81-32-Methyl-2-propanyl ...
Compound Q&A

What is N-(4-Chloro-2-pyridinyl)acetamide (CAS: 245056-66-0)?

N-(4-Chloro-2-pyridinyl)acetamide (CAS: 245056-66-0) is a chemical compound with...

245056-66-0N-(4-Chloro-2-pyridi...
Compound Q&A

What is 5-Chloro-2-hydroxybenzoic acid (CAS: 321-14-2)?

5-Chloro-2-hydroxybenzoic acid, also known as 5-chlorosalicylic acid, is an arom...

321-14-25-Chloro-2-hydroxybe...
Compound Q&A

What precautions should be taken when handling 1,1-Dichloro-1-fluoroethane (CAS: 1717-00-6)?

When handling 1,1-Dichloro-1-fluoroethane (CAS: 1717-00-6), it is important to u...

1717-00-61,1-Dichloro-1-fluor...
Compound Q&A

What are the physical and chemical properties of Fmoc-(2S,3R)-3-phenylpyrrolidine-2-carboxylic acid (CAS: 281655-32-1)?

Fmoc-(2S,3R)-3-phenylpyrrolidine-2-carboxylic acid is a white crystalline solid ...

281655-32-1Fmoc-(2S,3R)-3-pheny...
Compound Q&A

What are the main uses of 4-Amino-5-bromo-2-pyridinecarboxylic acid (CAS: 1363381-01-4)?

4-Amino-5-bromo-2-pyridinecarboxylic acid is primarily used as a precursor in th...

1363381-01-44-Amino-5-bromo-2-py...
1007881-98-2(S)-tert-butyl 2-((2...
Compound Q&A

What precautions should be taken when handling 8-bromo-2,2-dimethyl-3,4-dihydro-2H-1,4-benzoxazin-3-one (CAS: 688363-73-7)?

When handling 8-bromo-2,2-dimethyl-3,4-dihydro-2H-1,4-benzoxazin-3-one, use prop...

688363-73-78-bromo-2,2-dimethyl...

Source Journal

Physical Chemistry Chemical Physics

Physical Chemistry Chemical Physics
CiteScore: 5.5
Self-citation Rate: 10.3%
Articles per Year: 3036

Physical Chemistry Chemical Physics (PCCP) is an international journal co-owned by 19 physical chemistry and physics societies from around the world. This journal publishes original, cutting-edge research in physical chemistry, chemical physics and biophysical chemistry. To be suitable for publication in PCCP, articles must include significant innovation and/or insight into physical chemistry; this is the most important criterion that reviewers and Editors will judge against when evaluating submissions. The journal has a broad scope and welcomes contributions spanning experiment, theory, computation and data science. Topical coverage includes spectroscopy, dynamics, kinetics, statistical mechanics, thermodynamics, electrochemistry, catalysis, surface science, quantum mechanics, quantum computing and machine learning. Interdisciplinary research areas such as polymers and soft matter, materials, nanoscience, energy, surfaces/interfaces, and biophysical chemistry are welcomed if they demonstrate significant innovation and/or insight into physical chemistry. Joined experimental/theoretical studies are particularly appreciated when complementary and based on up-to-date approaches.

Recommended Compounds

Recommended Suppliers

Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.